Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank49
3Y CAGR-77.6%
5Y CAGR-37.9%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-77.6%/yr
Quarterly compound
5Y CAGR
-37.9%/yr
Recent deceleration
Percentile
P49
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.39% |
| Q3 2025 | -198.02% |
| Q2 2025 | 83.62% |
| Q1 2025 | -12272.54% |
| Q4 2024 | 98.80% |
| Q3 2024 | 21.16% |
| Q2 2024 | -442.41% |
| Q1 2024 | -783.47% |
| Q4 2023 | 98.06% |
| Q3 2023 | -163.78% |
| Q2 2023 | 241.64% |
| Q1 2023 | -122.38% |
| Q4 2022 | 477.92% |
| Q3 2022 | -15.17% |
| Q2 2022 | 24.91% |
| Q1 2022 | -15.39% |
| Q4 2021 | -155.19% |
| Q3 2021 | 49.45% |
| Q2 2021 | 23.30% |
| Q1 2021 | -547.62% |
| Q4 2020 | 58.23% |
| Q3 2020 | -86.92% |
| Q2 2020 | 28.37% |
| Q1 2020 | -57.31% |
| Q4 2019 | -165.80% |
| Q3 2019 | -130.36% |
| Q2 2019 | 272.61% |
| Q1 2019 | 6.11% |
| Q4 2018 | 15.19% |
| Q3 2018 | 13.34% |
| Q2 2018 | -2072.02% |
| Q1 2018 | -103.66% |
| Q4 2017 | 840.18% |
| Q3 2017 | 66.95% |
| Q2 2017 | 18.69% |
| Q1 2017 | -23.39% |
| Q4 2016 | 39.73% |
| Q3 2016 | -62.57% |
| Q2 2016 | 7.46% |
| Q1 2016 | -3.69% |